Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity

Get in-depth COVID-19 impact and recovery analysis on the Global Preventive Vaccines Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Global preventive vaccines market will reach $80.47 billion by 2026, growing by 11.26% annually over 2020-2026 owing to increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines.

    Highlighted with 110 tables and 84 figures, this 207-page report “Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire global preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides estimate/forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

    In-depth qualitative analyses include identification and investigation of the following aspects:

    • Market Structure

    • Growth Drivers

    • Restraints and Challenges

    • Emerging Product Trends & Market Opportunities

    • Porter’s Fiver Forces

    The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Region.

    Based on Vaccine Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Live/Attenuated Vaccines

    • Inactivated Vaccines

    • Subunit Vaccines

    • Toxoid Vaccines

    • Conjugate Vaccines

    • Recombinant Vector Vaccines

    • Other Vaccines

    Based on Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Vaccines for Pneumococcal Disease

    • Vaccines for Poliovirus

    • Vaccines for Hepatitis

    • Vaccines for Influenza

    • Vaccines for Measles, Mumps, and Rubella (MMR)

    • Vaccines for Varicella

    • Vaccines for Human Papilloma Virus

    • Vaccines for COVID-19

    • Vaccines for Other Diseases

    Based on Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Intramuscular Route

    • Subcutaneous Route

    • Oral Route

    • Intravenous Injection

    • Other Administration Routes

    Based on Patient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Pediatric Vaccines

    o Pneumococcal

    o Measles, Mumps, and Rubella (MMR)

    o Varicella

    o Hepatitis

    o Poliovirus

    o Haemophilus Influenzae B (HIB)

    o Other Diseases

    • Adult Vaccines

    o Influenza

    o Cervical Cancer

    o Hepatitis

    o Zoster

    o Other Diseases

    Geographically, the following regions together with the listed national/local markets are fully investigated:

    • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

    • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

    • North America (U.S., Canada, and Mexico)

    • South America (Brazil, Colombia, Argentina, Rest of South America)

    • MEA (Saudi Arabia, UAE, Egypt)

    For each region and key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of all regional markets by country and split of key national markets by Vaccine Type, Disease, and Route of Administration over the forecast years are also included.

    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

    Specifically, potential risks associated with investing in global preventive vaccines market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

    Key Players (this may not be a complete list and extra companies can be added upon request):

    AstraZeneca plc

    Bavarian Nordic A/S

    China National Biotec Group Company Ltd.

    CSL Ltd.

    Daiichi Sankyo Co. Ltd

    Emergent BioSolutions Inc.

    GlaxoSmithKline plc

    Johnson & Johnson

    Merck & Co.

    Moderna Inc.

    Novavax, Inc.

    Pfizer Inc.

    Sanofi SA

    Takeda Pharmaceutical Co. Ltd.

    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

     

  • With tables and figures helping analyze worldwide Global Preventive Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Introduction 9

    1.1 Industry Definition and Research Scope 9

    1.1.1 Industry Definition 9
    1.1.2 Research Scope 10

    1.2 Research Methodology 13

    1.2.1 Overview of Market Research Methodology 13
    1.2.2 Market Assumption 14
    1.2.3 Secondary Data 14
    1.2.4 Primary Data 14
    1.2.5 Data Filtration and Model Design 15
    1.2.6 Market Size/Share Estimation 16
    1.2.7 Research Limitations 17

    1.3 Executive Summary 18


    2 Market Overview and Dynamics 21

    2.1 Market Size and Forecast 21

    2.1.1 Impact of COVID-19 on World Economy 23
    2.1.2 Impact of COVID-19 on the Market 25

    2.2 Major Growth Drivers 27

    2.3 Market Restraints and Challenges 30

    2.4 Emerging Opportunities and Market Trends 33

    2.5 Porter’s Fiver Forces Analysis 37


    3 Segmentation of Global Market by Vaccine Type 41

    3.1 Market Overview by Vaccine Type 41

    3.2 Live/Attenuated Vaccines 43

    3.3 Inactivated Vaccines 44

    3.4 Subunit Vaccines 45

    3.5 Toxoid Vaccines 46

    3.6 Conjugate Vaccines 47

    3.7 Recombinant Vector Vaccines 48
    3.8 Other Vaccines 49

    4 Segmentation of Global Market by Disease 50

    4.1 Market Overview by Disease 50

    4.2 Vaccines for Pneumococcal Disease 52

    4.3 Vaccines for Poliovirus 53

    4.4 Vaccines for Hepatitis 54

    4.5 Vaccines for Influenza 55

    4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 56

    4.7 Vaccines for Varicella 57
    4.8 Vaccines for Human Papilloma Virus 58
    4.9 Vaccines for COVID-19 59
    4.10 Vaccines for Other Diseases 62

    5 Segmentation of Global Market by Administration 63

    5.1 Market Overview by Administration 63

    5.2 Intramuscular Route 65

    5.3 Subcutaneous Route 66

    5.4 Oral Route 67

    5.5 Intravenous Injection 68

    5.6 Other Administration Routes 69


    6 Segmentation of Global Market by Patient 70

    6.1 Market Overview by Patient 70

    6.2 Pediatric Vaccines 72

    6.3 Adult Vaccines 74


    7 Segmentation of Global Market by Region 76

    7.1 Geographic Market Overview 2020-2026 76

    7.2 North America Market 2020-2026 by Country 80

    7.2.1 Overview of North America Market 80
    7.2.2 U.S. 83
    7.2.3 Canada 88
    7.2.4 Mexico 91

    7.3 European Market 2020-2026 by Country 94

    7.3.1 Overview of European Market 94
    7.3.2 UK 97
    7.3.3 France 100
    7.3.4 Germany 103
    7.3.5 Spain 106
    7.3.6 Italy 109
    7.3.7 Russia 112
    7.3.8 Rest of European Market 115

    7.4 Asia-Pacific Market 2020-2026 by Country 117

    7.4.1 Overview of Asia-Pacific Market 117
    7.4.2 China 120
    7.4.3 Japan 123
    7.4.4 India 127
    7.4.5 Australia 130
    7.4.6 South Korea 133
    7.4.7 Rest of APAC Region 136

    7.5 South America Market 2020-2026 by Country 138

    7.5.1 Argentina 141
    7.5.2 Brazil 144
    7.5.3 Colombia 147
    7.5.4 Rest of South America Market 150

    7.6 MEA Market 2020-2026 by Country 151

    7.6.1 UAE 154
    7.6.2 Saudi Arabia 157
    7.6.3 Egypt 160
    7.6.4 Other National Markets 163

    8 Competitive Landscape 164

    8.1 Overview of Key Vendors 164

    8.2 New Product Launch, Partnership, Investment, and M&A 167

    8.3 Company Profiles 168

    AstraZeneca plc 168
    Bavarian Nordic A/S 171
    China National Biotec Group Company Ltd. 174
    CSL Ltd. 176
    Daiichi Sankyo Co. Ltd 178
    Emergent BioSolutions Inc. 180
    GlaxoSmithKline plc 182
    Johnson & Johnson 186
    Merck & Co. 188
    Moderna Inc. 190
    Novavax, Inc. 191
    Pfizer Inc. 193
    Sanofi SA 197
    Takeda Pharmaceutical Co. Ltd. 199

    9 Investing in Global Market: Risk Assessment and Management 201

    9.1 Risk Evaluation of Global Market 201

    9.2 Critical Success Factors (CSFs) 204

    Related Reports and Products 207

     

  • The Global Preventive Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • AstraZeneca plc Bavarian Nordic A/S China National Biotec Group Company Ltd. CSL Ltd. Daiichi Sankyo Co. Ltd Emergent BioSolutions Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co. Moderna Inc. Novavax
    • Inc. Pfizer Inc. Sanofi SA Takeda Pharmaceutical Co. Ltd.
    By Regions:
      By Type:
        By Application:
        Licensing options
        3200
        USD

        Need assistance ?

        Research objectives

        Where will all these developments take the industry in the long

        To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

        What are the future opportunities in the market?

        To understand the structure of Market by identifying its various subsegments.

        What are the major driving forces expected to impact the development of the market market across different regions?

        To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

        Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

        To project the consumption of market submarkets, with respect to key regions.

        Who are the major driving forces expected to decide the fate of the industry worldwide.

        To strategically profile the key players and comprehensively analyze their growth strategies.

        What are the key barriers and threats believed to hinder the development of the industry?

        To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

        Who are the prominent market players making a mark in the market with their winning strategies?

        To share detailed information about the key factors influencing the growth of the market

        What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

        Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

        Our Clients